Renal Denervation for Treatment of Resistant Hypertension in Patients With Chronic Kidney Disease
Catheter-based Renal Sympathetic Nerve Ablation for Treatment-resistant Hypertension in Patients With Chronic Kidney Disease
Sponsor: National Heart Centre Singapore
Listed as NCT01747382, this observational or N/A phase trial focuses on Chronic Kidney Disease and Hypertension and remains ongoing. Sponsored by National Heart Centre Singapore, it has been updated 8 times since 2012, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
No Longer Available
-
Jul 2024 — Sep 2024 [monthly]
No Longer Available
-
Jan 2021 — Jul 2024 [monthly]
No Longer Available
-
Sep 2020 — Jan 2021 [monthly]
No Longer Available
-
Jun 2018 — Sep 2020 [monthly]
No Longer Available
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
No Longer Available
Phase: NA → None
-
Jun 2017 — Apr 2018 [monthly]
No Longer Available NA
Status: Unknown Status → No Longer Available · Phase: PHASE2 → NA
-
Jan 2017 — Jun 2017 [monthly]
Unknown Status PHASE2
First recorded
Apr 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart Centre Singapore
- Singapore General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .